第一单位：
Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institut für Klinische Pharmakologie und Toxikologie, Berlin, Germany.
作者：
Reinhold,Kreutz [1]
;
Piotr,Dobrowolski [2]
;
Aleksander,Prejbisz [2]
;
Engi A E-H,Algharably [1]
;
Grzegorz,Bilo [3]
;
Felix,Creutzig [4]
;
Guido,Grassi [5]
;
Vasilios,Kotsis [6]
;
Dragan,Lovic [7]
;
Empar,Lurbe [8]
;
Pietro A,Modesti [9]
;
Marco,Pappaccogli [10]
;
Gianfranco,Parati [3]
;
Alexandre,Persu [11]
;
Jorge,Polonia [12]
;
Marek,Rajzer [13]
;
Philippe,de Timary [14]
;
Thomas,Weber [15]
;
Burkhard,Weisser [16]
;
Konstantinos,Tsioufis [17]
;
Giuseppe,Mancia [18]
;
Andrzej,Januszewicz [2]
;
European Society of Hypertension COVID-19 Task Force Review
作者单位：
Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institut für Klinische Pharmakologie und Toxikologie, Berlin, Germany.
[1]
Department of Hypertension, National Institute of Cardiology, Warsaw, Poland.
[2]
Department of Cardiovascular, Neural and Metabolic Sciences, IRCCS Istituto Auxologico Italiano.;Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
[3]
Mercator Research Institute on Global Commons and Climate Change.;Technical University Berlin, Berlin, Germany.
[4]
Clinica Medica, University Milano Bicocca, Milan, Italy.
[5]
3rd Department of Internal Medicine Aristotle University Thessaloniki, Hypertension-24 h Ambulatory Blood Pressure Monitoring Center, Papageorgiou Hospital, Thessaloniki, Greece.
[6]
Cardiology Department, Clinic for Internal Disease Intermedica, Singidunum University, School of Medicine, Nis, Serbia.
[7]
Pediatric Department, Consorcio Hospital General, University of Valencia.;CIBER Fisiopatología Obesidad y Nutrición (CB06/03), Instituto de Salud Carlos III, Valencia, Spain.
[8]
Department of Experimental and Clinical Medicine, Universita' degli Studi di Firenze, School of Medicine, Azienda Ospedaliero Universitaria Careggi, Firenze.
[9]
Hypertension Unit, Division of Internal Medicine, Department of Medical Sciences, University of Turin, Turin, Italy.;Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique and Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
[10]
Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique and Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
[11]
Department of Medicine and CINTESIS, Faculty of Medicine, Porto University, Porto, Portugal.
[12]
1st Department of Cardiology, Interventional Electrocardiology and Arterial Hypertension Jagiellonian University Medical College, Kraków, Poland.
[13]
Department of Adult Psychiatry, Cliniques Universitaires Saint-Luc and Institute of Neuroscience, Université Catholique de Louvain, Brussels, Belgium.
[14]
Cardiology Department, Klinikum Wels-Grieskirchen, Wels, Austria.
[15]
Institute of Sport Science, University of Kiel, Kiel, Germany.
[16]
First Cardiology Clinic, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece.
[17]
Università Milano-Bicocca, Milan.;Policlinico di Monza, Monza, Italy.
[18]
DOI
10.1097/HJH.0000000000002770
PMID
33395152
发布时间
2023-09-11
换一批
换一批
